-
Immunotherapy in MSS CRC: Evolving Therapies and Updates - 3 day(s) ago
John Marshall, MD
Dear readers, For those of us who have been at this for a few decades, the miracle of immune therapy continues to amaze. Our immune…
-
John Marshall, MD
Dear readers, The 2025 ASCO Annual Meeting represents a landmark moment for the management of metastatic colorectal cancer (CRC). Specifically, we must now perform molecular…

Colorectal Cancer
John Marshall, MD, of the Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, discusses the top news and updates in colorectal cancer.
Experts in this Learning Lab
Dr. Marshall is an internationally recognized expert in new drug development for GI cancer and has served as Principal Investigator for more than one hundred clinical trials throughout his career. He established the Otto J Ruesch Center for the Cure of GI Cancers as well as the Precision Oncology Alliance. He currently serves as the Oncology CMO for Indivumed. Dr. Marshall received his training at Duke University, the University of Louisville, and Georgetown University.
Collections